▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / LDDD

LDDD — Longduoduo Co Ltd

—
OTC · Health Care · Health Care Providers & Services · CIK 1892316 · China
Last close
$0.51
Market Cap
$15.31M
52W High
$1.10
52W Low
$0.51
ADV30
0
Next earnings
—
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Mar 2026 187,392 184,055 -197,443 -166,208 1,748,643 1,224,881 957,123
Dec 2025 345,265 339,994 -279,193 -258,495 2,102,584 1,543,479 1,144,659
Sep 2025 658,764 652,054 -84,414 -90,954 1,899,291 1,247,296 700,555
Jun 2025 940,376 930,778 131,000 163,145 2,126,496 1,642,721 830,464

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-253,666
Investing CF
$-60,284
Financing CF
$0
CapEx
$-60,284
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.02
As of
2026-10-05

Balance + Analyst (yfinance extras)

Retained Earnings
$-6,684,854
Inventory
—
Receivables
$67,406
ST Investments
—
EBIT TTM
$-430,050
Pretax Income TTM
$-226,186
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,822,457
EBITDA
$-522,517
Free Cash Flow
$106,663
Enterprise Value
$13,819,882
Total Cash
$1,588,930
Total Debt
$49,070
Shares Out
30,015,036
Trailing EPS
$-0.01
Book Value
$0.03
ROE
-62.6%
ROA
-18.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2025 4,262,663 552,679 460,435 2,126,496 830,464 1,184,565 277,365
Jun 2024 7,389,842 2,026,141 1,255,448 2,063,401 1,282,550 702,515 582,282
Jun 2023 3,818,560 29,238 -39,089 1,482,782 2,053,437 -541,957 965,337
Jun 2022 3,237,993 -7,555,286 -7,517,365 610,667 1,633,006 -928,786 28,572

TTM Snapshot

Revenues TTM
$2,131,797
NetIncome TTM
$-352,512
OpCashFlow TTM
—
Assets (Latest)
$1,748,643
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
XCRT Xcelerate, Inc. $12.16M $0.03 —
PFHO PACIFIC HEALTH CARE ORGANIZATION INC $12.03M $0.94 —
PIII P3 Health Partners Inc. $20.77M $5.31 —
ADVB Advanced Biomed Inc. $10.11M $6.12 —
EHSI Elite Health Systems Inc. $24.24M $0.85 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →